• Scope and Methodology
• Size and Growth of the Market
• Market Trends
  • Positive Trends
  • Negative Trends

Chapter Two: Introduction

• Background
• The Many Faces of CVD
• The Pros and Cons of Early Diagnosis
• Point of View
• The Market Environment for CVD Diagnostics

Chapter Three: Market Dynamics in Cardiac Disease Testing

• Background
• Cardiovascular Diseases and Population Trends in Major World Markets
• Cardiac Disease Diabetes Link
• Cardiac Disease Lipids Link
• Cardiac Disease Coagulation Link
• Cardiac Disease Inflammation Link
• Cardiac Disease Infection Link
• Cardiac Disease Genetics Link
• POC Testing in the Home, POL, and Hospital
  • Self Testing
  • Clinic and Physician Office Lab Testing
  • In the Hospital
  • Home Telemedicine Initiatives
  
  
• The Role of In Vivo and Imaging Test Modalities

Chapter Four: Market Analysis

• Market Overview
• Decentralized Testing
• Lab-Based Testing
• Acute Myocardial Infarction Cell Necrosis Enzymes/BNP
• Coagulation Factors
• hsCRP, Homocysteine, and Inflammation Markers
• Lipids
• Specific Enzymes and Proteins
• Genetic Markers
• Pharmacodiagnostic Testing (PGx)
• Emerging Tests and Technologies
• Commercial Outlook

Chapter Five: Competitors and Innovators

• The Top IVD Companies and Their CVD Offerings
  • Abbott Diagnostics
  • Bayer HealthCare, Diagnostics Division (Acquired by Siemens Medical)
  • Beckman Coulter Inc.
  • bioMerieux Inc.
  • Dade Behring Inc.
  • Daiichi Pure Chemicals Co., Ltd.
  • Diagnostic Product Corporation (DPC) (Acquired by Siemens Medical)
  • Instrumentation Laboratory (IL)
  • Mitsubishi Kagaku Iatron, Inc.
  • Ortho Clinical Diagnostics
  • Roche Diagnostics

• CVD Product Innovators
  • Accumetrics Inc.
  • Agen Biomedical Ltd.
  • Alpco Diagnostics
  • Asia-Lion Biotechnology Co., Ltd.
  • Axis-Shield plc
  • Bender MedSystems GmbH
  • Biophysical Corp.
  • Biosite Inc.
  • Celera Diagnostics
  • Cholestech Corp.
  • Clinical Data, Inc. (formerly Novitron International, Inc.)
  • Competitive Technologies, Inc.
  • CompuCyte Corp.
  • Corgenix Medical Corp.
  • diaDexus, Inc.
  • deCODE Genetics
  • Forbes Medi-Tech Inc.
  • Genaissance Pharmaceuticals, Inc.
  • IntraCellular Diagnostics, Inc.
  • Ischemia Technologies, Inc./Inverness Medical Innovations
  • LipoScience
  • Myriad Genetics, Inc.
  • Nanogen Inc.
  • Oxford Biosensors Ltd.
  • OXIS International Inc.
  • PlaCor, Inc.
  • Polymer Technology Systems, Inc.
  • PreMD Inc.
  • PrognostiX Inc.
  • Rennesens GmbH
  • Response Biomedical Corp.
  • Source MDx
  • Third Wave Technologies, Inc.
  • ThromboVision, Inc.
  • Trinity Biotech plc/Biopool International/Ameleung

List of Exhibits

Chapter One: Executive Summary

• Exhibit 1: Market Summary: Worldwide Market for Cardiac IVDs 2000-2005

Chapter Three: Market Dynamics in Cardiac Disease Testing

• Exhibit 2: Selected IVD Markers of CVD by Type
• Exhibit 3: Cardiovascular Diseases Among Diabetics, Nondiabetics, and All U.S. Adults
• Exhibit 4: Estimated Number of Preventable Diabetes Cases and Complications in the United States
• Exhibit 5: Selected Genetic Tests and Therapeutic Targets
• Exhibit 6: Selected Companies Developing Cardiovascular Genomic Therapies
• Exhibit 7: Selected OTC Cardiac Metabolic and Genetic Tests Available Online
• Exhibit 8: Selected Pharmacodiagnostic Platelet Function tests
• Exhibit 9: Selected POC Devices for Professional Use (Company, Location, Target, Test, Status)

Chapter Four: Market Analysis

• Exhibit 10: Worldwide Sales of Selected Cardiac IVDs by Type [Cholesterol/Lipid Markers (Laboratory), Cholesterol/Lipid Markers (POC Professional), Cholesterol/Lipid Markers (POC OTC), CRP/Inflammation Markers, Enzymes, Special, AMI Enzymes(Laboratory), AMI (POC), BNP, Coagulation Markers, Homocysteine, D-Dimer, Gene Thrombophilia Markers] 2005, 2010
• Exhibit 11: Geographic Distribution of Product Sales in CVD IVD Testing (North America; European Union; Japan; Latin America/India/Asia Pac/Middle East; ROW)
• Exhibit 12: Worldwide Sales of Acute Myocardial Infarction IVD Tests by Type (Enzymes [special], AMI Enzymes, AMI [POC], BNP) 2005-2010
• Exhibit 13: Worldwide Sales of Lipid IVD Tests by Type (Laboratory, POC Professional, POC OTC) 2005-2010